Scinovex
article Open Access

Acute fatal canine monocytic ehrlichiosis in a young Pup

International Journal of Advanced Biochemistry Research · 2026 · Vol. 10(8) · pp. 115–117

Abstract

Canine monocytic ehrlichiosis (CME), caused by Ehrlichia canis, is a life-threatening tick-borne disease characterized by hematological abnormalities and hemorrhagic manifestations. This report presents a fatal case of CME in a 8-month-old female Husky pup presented to veterinary hospital in Vijayawada with unilateral epistaxis, labored breathing and severe weakness. Clinical examination revealed marked pallor of the mucous membranes. Hematological evaluation demonstrated severe anemia with neutrophilia. Giemsa-stained peripheral blood smear examination revealed characteristic intracytoplasmic morulae within circulating monocytes. The diagnosis was further confirmed by a rapid immunochromatographic antibody assay and polymerase chain reaction (PCR) targeting the virB9 gene of Ehrlichia canis. Despite prompt initiation of doxycycline therapy along with intensive supportive management, the dog deteriorated rapidly and succumbed within 48 hours of presentation. This case underscores the grave prognosis associated with severe hemorrhagic manifestations of canine monocytic ehrlichiosis in young dogs, particularly when the disease is recognized at an advanced stage.

Full Text

Tables and figures are in the full-text PDF.

Introduction

Canine monocytic ehrlichiosis (CME) is a globally distributed tick-borne disease caused by Ehrlichia canis, an obligate intracellular Gram-negative bacterium belonging to the family Anaplasmataceae. The disease is transmitted predominantly by the brown dog tick, Rhipicephalus sanguineus sensu lato, particularly in tropical and subtropical regions where the vector thrives throughout the year (Greene, 2022) [2] . Following transmission through tick feeding, the disease progresses through acute, subclinical and chronic phases, producing a wide range of clinical manifestations including fever, anorexia, lethargy, lymphadenopathy, pale mucous membranes, thrombocytopenia, epistaxis, petechial haemorrhages and ocular abnormalities. Bleeding manifestations are among the most characteristic clinical findings and generally result from thrombocytopenia, platelet dysfunction, vasculitis and coagulation abnormalities (Harrus and Waner, 2011; Waner et al., 2001) [5,7] . Chronic infection may result in severe bone marrow suppression, pancytopenia and immune-mediated complications, which can be fatal if left untreated (Neer et al., 2002). The clinical diagnosis of CME is often difficult because its manifestations overlap with those of other canine vector-borne diseases such as babesiosis, anaplasmosis and hepatozoonosis. Furthermore, the severity of disease is influenced by host immunity, stage of infection and the degree of tick infestation (Waner et al., 2001; Kottadamane et al., 2017) [7] . Consequently, understanding the clinical profile and epidemiological characteristics of the disease is essential for early recognition and effective case management.

Case History

A 8-month-old female Husky (Case No. 1899) was presented to the veterinary hospital in Vijayawada with a history of unilateral epistaxis (Fig. 1), anorexia and labored breathing. According to the owner, the bleeding had progressively increased over the preceding day and was accompanied by weakness and reduced activity. Physical examination revealed severe depression and marked pallor of the conjunctival and oral mucous membranes suggestive of significant anemia. No obvious external traumatic lesion was observed.

Based on the history and physical examination ticks were recovered from the pup and further hematological investigation was undertaken to determine the underlying cause along with further investigations.

Results and Discussion

Complete hematological examination revealed marked anemia accompanied by neutrophilic leukocytosis. Giemsastained peripheral blood smear examination demonstrated characteristic basophilic intracytoplasmic morulae within circulating monocytes, providing direct microscopic evidence of E. canis infection (Fig. 2). Based on the clinical presentation together with hematological findings, the case was diagnosed as acute canine monocytic ehrlichiosis. Consequently, further diagnostic confirmation was performed using a rapid immunochromatographic assay for the detection of Ehrlichia canis-specific antibodies (Fig. 3), followed by molecular confirmation through conventional PCR amplification of the virB9 gene (Fig. 4). Amplification of the expected PCR product confirmed the presence of E. canis DNA, establishing active infection and validating the hematological and serological findings. Despite timely therapeutic intervention, the dog succumbed within 48 hours of presentation, indicating an advanced stage of disease with extensive systemic involvement. The rapid clinical deterioration was most likely attribute to severe hematological abnormalities and hemorrhagic manifestations, which are recognized indicators of poor prognosis in CME. Hemorrhage results primarily from thrombocytopenia, platelet dysfunction, immune-mediated platelet destruction and vascular injury caused by widespread vasculitis. (Harrus et al., 1999; Greene, 2022) [2,4] . Marked pallor and severe anemia reflected extensive hematological involvement. Anemia in ehrlichiosis develops through multiple mechanisms including blood loss, immune-mediated erythrocyte destruction, inflammatory suppression of erythropoiesis and bone marrow dysfunction (Harrus et al., 1997) [3] . Diagnosis of CME should ideally integrate clinical findings with laboratory confirmation. Peripheral blood smear examination provides rapid evidence when morulae are present but lacks sensitivity. Serological tests such as rapid immunochromatographic assays are useful screening tools for detecting anti-Ehrlichia antibodies; however, positive antibody tests cannot differentiate active infection from previous exposure because antibodies may persist after recovery. In contrast, PCR detects bacterial DNA directly and is regarded as one of the most reliable methods for confirming active infection, particularly when targeting conserved genes such as virB9 (Iqbal and Rikihisa, 1994; Harrus and Waner, 2011) [5,6,7] . The present case involved a young Husky that developed a rapidly progressive and fatal form of canine monocytic ehrlichiosis despite prompt initiation of doxycycline therapy and intensive supportive management. This observation is in agreement with previous reports indicating that German Shepherds and Siberian Huskies are predisposed to developing severe clinical disease with an unfavorable prognosis following Ehrlichia canis infection (Aziz et al., 2022) [1] . The heightened susceptibility of these breeds has been attributed to breed-associated variations in host immune responses, which may predispose affected dogs to more severe hematological abnormalities and systemic complications. The fatal outcome within two days emphasizes that advanced ehrlichiosis remains associated with a guarded prognosis, particularly when hemorrhagic manifestations and severe anemia are already evident at presentation. Early diagnosis followed by prompt doxycycline therapy remains essential for improving survival.

Conclusion

This report documents a fatal case of acute canine monocytic ehrlichiosis in a young Husky-dog presenting with unilateral epistaxis, severe anemia and neutrophilia. Diagnosis was established by demonstration of Ehrlichia canis morulae in peripheral blood smears, positive rapid immunochromatographic antibody testing and molecular confirmation using virB9 gene PCR. The case highlights the diagnostic value of combining hematological, serological and molecular techniques for accurate diagnosis of CME and underscores the importance of early therapeutic intervention in dogs presenting with spontaneous hemorrhage.

Acknowledgement

AcknowledgmentsThe authors express their sincere gratitude to the Sri Venkateswara Veterinary University (SVVU), Tirupati, Andhra Pradesh, India, for providing the necessary facilities, infrastructure and institutional support to carry out this research. Appreciation is extended to the veterinarians, dog owners and supporting staff who cooperated during sample collection and clinical investigations.

References

  1. Aziz MU, Hussain S, Song B, Ghauri HN, Zeb J, Sparagano OAE. Ehrlichiosis in dogs: A comprehensive review about the pathogen and its vectors with emphasis on South and East Asian countries. Veterinary Sciences. 2023;10(1):21.
  2. Greene CE. Infectious Diseases of the Dog and Cat. 5th ed. St. Louis: Elsevier; 2022.
  3. Harrus S, Kass PH, Klement E, Waner T. Canine monocytic ehrlichiosis: A retrospective study of 100 cases, and an epidemiological investigation of prognostic indicators for the disease. Veterinary Record. 1997;141(14):360-363.
  4. Harrus S, Waner T, Bark H, Jongejan F, Cornelissen AWCA. Recent advances in determining the pathogenesis of canine monocytic ehrlichiosis. Journal of Clinical Microbiology. 1999;37(9):2745-2749.
  5. Harrus S, Waner T. Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): An overview. Veterinary Journal. 2011;187(3):292-296.
  6. Rikihisa Y. Anaplasma phagocytophilum and Ehrlichia canis: Subversive manipulators of host cells. Nature Reviews Microbiology. 2010;8(5):328-339.
  7. Waner T, Harrus S, Jongejan F, Bark H, Keysary A, Cornelissen AWCA. Significance of serological testing for ehrlichial diseases in dogs with special emphasis on the diagnosis of canine monocytic ehrlichiosis caused by Ehrlichia canis. Veterinary Parasitology. 2001;95(1):1-15.
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
63%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.